120 related articles for article (PubMed ID: 2048017)
1. [Etiologic and pathologic approaches to pharmacotherapy of peptic ulcer].
Grigor'ev PIa; Isakov VA
Ter Arkh; 1991; 63(2):27-30. PubMed ID: 2048017
[TBL] [Abstract][Full Text] [Related]
2. [The role of Helicobacter pylori in the etiology of peptic ulcer and its therapy].
Köksal H
Mikrobiyol Bul; 1993 Jul; 27(3):266-70. PubMed ID: 8361417
[TBL] [Abstract][Full Text] [Related]
3. [Helicobacter pylori: an etiologic factor in chronic gastritis, gastroduodenal ulcer and gastric cancer].
Ausina V
Med Clin (Barc); 1995 Nov; 105(15):576-9. PubMed ID: 7500677
[No Abstract] [Full Text] [Related]
4. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.
Brzozowski T; Konturek PC; Sliwowski Z; Kwiecień S; Drozdowicz D; Pawlik M; Mach K; Konturek SJ; Pawlik WW
J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():67-79. PubMed ID: 17033106
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori-negative peptic ulcers: frequency and implications for management.
Freston JW
J Gastroenterol; 2000; 35 Suppl 12():29-32. PubMed ID: 10779214
[TBL] [Abstract][Full Text] [Related]
6. [Healing peptic ulcer disease with therapy of Helicobacter pylori infection--an overview].
Leodolter A; Peitz U; Malfertheiner P
Wien Med Wochenschr; 2001; 151(13-14):300-8. PubMed ID: 11582994
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori in ulcerogenesis.
Lin SK; Lambert JR
Scand J Gastroenterol Suppl; 1995; 210():64-9. PubMed ID: 8578211
[TBL] [Abstract][Full Text] [Related]
8. Highly significant change of the clinical course of relapsing and complicated peptic ulcer disease after cure of Helicobacter pylori infection.
Labenz J; Börsch G
Am J Gastroenterol; 1994 Oct; 89(10):1785-8. PubMed ID: 7942667
[TBL] [Abstract][Full Text] [Related]
9. The role of Helicobacter pylori in peptic ulcer disease.
Partipilo ML; Woster PS
Pharmacotherapy; 1993; 13(4):330-9. PubMed ID: 8361859
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI.
Ohara T; Morishita T; Suzuki H; Masaoka T; Ishii H
Hepatogastroenterology; 2004; 51(56):338-42. PubMed ID: 15086153
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
Park KN; Hahm JS; Kim HJ
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
[TBL] [Abstract][Full Text] [Related]
12. Current indications for acid suppressants in Helicobacter pylori -negative ulcer disease.
Howden CW; Leontiadis GI
Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):401-12. PubMed ID: 11403535
[TBL] [Abstract][Full Text] [Related]
13. The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti-inflammatory drug use is negligible in southern Europe.
Arroyo MT; Forne M; de Argila CM; Feu F; Arenas J; de la Vega J; Garrigues V; Mora F; Castro M; Bujanda L; Cosme A; Castiella A; Gisbert JP; Hervas A; Lanas A
Helicobacter; 2004 Jun; 9(3):249-54. PubMed ID: 15165261
[TBL] [Abstract][Full Text] [Related]
14. An etiologic approach to management of duodenal and gastric ulcers.
Rex DK
J Fam Pract; 1994 Jan; 38(1):60-7. PubMed ID: 8289053
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori-negative ulcer disease.
McColl KE
J Gastroenterol; 2000; 35 Suppl 12():47-50. PubMed ID: 10779218
[TBL] [Abstract][Full Text] [Related]
16. Immediate eradication of Helicobacter pylori in patients with previously documented peptic ulcer disease: clinical and economic effects.
Fendrick AM; McCort JT; Chernew ME; Hirth RA; Patel C; Bloom BS
Am J Gastroenterol; 1997 Nov; 92(11):2017-24. PubMed ID: 9362183
[TBL] [Abstract][Full Text] [Related]
17. [Helicobacter pylori in peptic ulcer and gastric cancer].
Matsukura N; Onda M; Yamashita K
Gan To Kagaku Ryoho; 1995 Feb; 22(2):169-78. PubMed ID: 7857088
[TBL] [Abstract][Full Text] [Related]
18. [Gastroduodenal ulcer disease: therapeutic possibilities].
Inauen W
Praxis (Bern 1994); 1995 May; 84(20):585-9. PubMed ID: 7761731
[TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori and peptic ulcer disease.
Feldman M; Peterson WL
West J Med; 1993 Nov; 159(5):555-9. PubMed ID: 8279151
[TBL] [Abstract][Full Text] [Related]
20. Study of outcome after targeted intervention for peptic ulcer resistant to acid suppression therapy.
Lanas A; Remacha B; Sáinz R; Hirschowitz BI
Am J Gastroenterol; 2000 Feb; 95(2):513-9. PubMed ID: 10685760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
